It’s a bad time to try to predict future pharmaceutical prices.

Lilly has been chasing—and gaining on—its chief metabolic medicine rival Novo Nordisk and its counterpart GLP-1s Ozempic and ...

As investors and industry watchers juggle the twin possibilities of pharmaceutical import tariffs and potential drug pricing ...

US President Donald Trump recently announced tariffs as high as 100% on certain semiconductor products. Although South Korea ...

The Bajhang-born fighter, who refused an offer to represent India, has become Nepal’s first international MMA champion after ...

Aside from the MFN order, President Trump is also in the process of negotiating tariffs with countries all over the world. It ...

George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest ...

The Trump Administration is pursuing decidedly anti-growth policies. The results will be a weaker economy that violates his ...

The U.S. government has been discussing with drugmakers how to raise overseas drug prices as President Donald Trump seeks to ...

Trump’s MFN price controls on drugs will harm U.S. companies and patients.

The Arizona congressional delegation should stand up for our bioscience sector and oppose any policy like Most Favored Nation ...

German drugmaker Merck KGaA on Thursday joined peers in saying it was considering distribution models that serve U.S.